Large-scale testing (Phase 3)Study completedNCT01471574
What this trial is testing
Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus
Who this might be right for
Hepatitis C, Genotype 1
Bristol-Myers Squibb 549